Literature DB >> 24798999

Allopurinol overuse in asymptomatic hyperuricemia: a teachable moment.

Carla Carnovale1, Mauro Venegoni2, Emilio Clementi3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24798999     DOI: 10.1001/jamainternmed.2014.1427

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN: 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  6 in total

Review 1.  Treatment of asymptomatic hyperuricemia complicated by renal damage: a controversial issue.

Authors:  Chun Hu; Xiaoyan Wu
Journal:  Int Urol Nephrol       Date:  2019-08-28       Impact factor: 2.370

2.  Inappropriate prescription of allopurinol and febuxostat and risk of adverse events in the elderly: results from the REPOSI registry.

Authors:  L Pasina; A L Brucato; C D Djade; P Di Corato; S Ghidoni; M Tettamanti; C Franchi; F Salerno; S Corrao; A Marengoni; M Marcucci; P M Mannucci; A Nobili
Journal:  Eur J Clin Pharmacol       Date:  2014-09-18       Impact factor: 2.953

3.  Role of Community Pharmacies for the Detection of Potentially Inappropriate Xanthine Oxidase Inhibitor Prescriptions.

Authors:  L Pasina; S A M Urru; P Minghetti; C Giua
Journal:  Drugs Real World Outcomes       Date:  2015-03

4.  Allopurinol prescription patterns among patients in a Saudi tertiary care centre.

Authors:  Naji A Dwid; Mohamed M Cheikh; Ahmed S Mandurah; Khaldoun A Shikh-Souk; Khaled R Al-Khatib; Ans R Ahmed
Journal:  J Taibah Univ Med Sci       Date:  2020-04-27

5.  Severe Cutaneous Adverse Drug Reactions Associated with Allopurinol: An Analysis of Spontaneous Reporting System in Southern Italy.

Authors:  Cristina Scavone; Cristina Di Mauro; Rosanna Ruggiero; Francesca Futura Bernardi; Ugo Trama; Maria Luisa Aiezza; Concetta Rafaniello; Annalisa Capuano
Journal:  Drugs Real World Outcomes       Date:  2020-03

Review 6.  An Updated Review of Genetic Associations With Severe Adverse Drug Reactions: Translation and Implementation of Pharmacogenomic Testing in Clinical Practice.

Authors:  Chuang-Wei Wang; Ivan Arni C Preclaro; Wei-Hsiang Lin; Wen-Hung Chung
Journal:  Front Pharmacol       Date:  2022-04-25       Impact factor: 5.988

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.